Beacon Closes Seed Round

Chicago Startup Beacon Is Transforming How Indoor Spaces Are Disinfected

Beacon closes Seed Round to accelerate next phase of growth and product expansion

CHICAGO, IL –  May 29, 2025 – Beacon Technology Solutions, Inc. (Beacon), a Chicago-based company pioneering the use of Far-UVC 222nm disinfection technology in commercial and consumer settings, announced today the successful closing of its $1.6M Seed funding round. The round includes participation from Harper Court Ventures and HIP.

The funding will fuel Beacon's continued expansion, including the public launch of its V2 product, which is set to debut in the months ahead. It will also bolster the company's sales and marketing initiatives, and enable further development of impact measurements.

"We’re proud to welcome our new partners to the Beacon team," said Brian Clark, CEO and Co-founder of Beacon. "This milestone marks a significant chapter for us. Working with investors who share our vision of improving the health of businesses and consumers with new smart technology is key to scaling our impact. Together, we're building something truly meaningful."

Beacon is reimagining how businesses and consumers disinfect indoor spaces through app-controlled smart devices that safely inactivate airborne and surface pathogens in real time. Beacon’s patented technology is safe for use in occupied spaces, and has already been deployed in both commercial and home environments, helping users protect health with effortless, continuous disinfection.

Beacon’s Seed Round is funded by investors including The University of Chicago’s Harper Court Ventures, which brings deep experience in supporting early-stage technology and health innovation startups.

“We’re excited to partner with Beacon on this journey,” said Karthee Madasamy, General Partner at Harper Court Ventures. “They’re addressing a major challenge in healthcare with a thoughtful, science-driven approach. The strength of their team, clarity of vision, and unique market position give them the potential to reshape how people think about their health freedom–and we’re proud to support that mission."

Also participating in the round is HIP, a national healthtech investment fund:

“We are pleased to back Beacon as they pioneer a new era of indoor health and safety,” commented Samir Batra, Managing Partner of HIP. “Their novel disinfection technology is not just a groundbreaking solution, but a crucial step towards reimagining how we protect public health in shared spaces.”

In the weeks ahead, Beacon will launch sales for its V2, which includes a sleek and modern design, advanced scheduling features, and enhanced connectivity for a wide range of use cases.

"Beacon is establishing a new era in reducing infection transmission in high risk settings,” commented Howard Fullman, Former Medical Director at Kaiser Permanente, West Los Angeles, who leads Beacon’s Medical Advisory Board. “This cutting edge technology addresses the societal need to keep people safe during local and community infection outbreaks in healthcare, educational, nursing homes, cruises, and other settings."

For more information on Beacon and to sign up for updates, visit www.beaconlight.co.

About Beacon

Beacon Technology Solutions, Inc. (Beacon) is a healthtech company redefining indoor safety through intelligent Far-UVC 222nm disinfection. Beacon's namesake technology helps mitigate up to 99.99% of airborne and surface pathogens including viruses, bacteria, and mold. Beacon is safe for use in occupied spaces, offering users real-time, continuous disinfection. Beacon donates 5% of its proceeds to bringing its proprietary technology to underserved organizations and communities. With its patented technology, Beacon empowers both organizations and consumers to create healthier, smarter environments. Learn more at www.beaconlight.co.